Therapy Areas: Oncology
23 February 2024 - Pharmaceutical company Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ), announced on Friday that it has received a positive opinion from the Committee for Medicinal Produc...
23 February 2024 - Delcath Systems, Inc. (Nasdaq: DCTH), a New York-based interventional oncology company, announced on Thursday that it has introduced a Healthcare Setting Locator (Locator) on the he...
23 February 2024 - TC BioPharm (Holdings) PLC (TCBP) (NASDAQ: TCBP) a UK-based clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other ind...
23 February 2024 - Elevation Oncology, Inc. (Nasdaq: ELEV), a US-based innovative oncology company, announced on Thursday that it has expanded its ongoing Phase one clinical trial of EO-3021 outside t...
23 February 2024 - Astellas Pharma Inc, a United States affiliate of Japan-based Astellas Pharma Inc., announced on Thursday that it has appointed Michael Petroutsas as its new head, United States Com...
21 February 2024 - Clinical-stage immunotherapy firm ImmunityBio (NASDAQ: IBRX), completes accrual of the first two phases of a national trial assessing its Nant Cancer Vaccine (NCV) in participants w...